Epigenetic profiling of hormone receptor positive breast cancer and the risk of disease recurrence

Timotheus Cornelius Kaspar Giovanni de Ruijter

Research output: ThesisDoctoral ThesisInternal

441 Downloads (Pure)

Abstract

This thesis investigated whether the development of metastases in patients treated for hormone-sensitive breast cancer can be predicted on the basis of the DNA methylation profile of the tumor. The thesis consists of a main study investigating the prognostic value of DNA methylation in Dutch patients, and a number of technical studies that made the analyses in the main study possible. The conclusion of the study is that DNA methylation has a predictive value for the occurrence of metastases in women treated for hormone-sensitive breast cancer, but that this predictive value is no better than already existing clinical factors.
Original languageEnglish
Awarding Institution
  • Maastricht University
Supervisors/Advisors
  • Tjan - Heijnen, Vivianne, Supervisor
  • van Engeland, Manon, Supervisor
  • Smits, Kim, Co-Supervisor
  • Aarts - Essers, Maureen, Co-Supervisor
Award date4 Jul 2022
Place of PublicationMaastricht
Publisher
Print ISBNs9789464195316
DOIs
Publication statusPublished - 2022

Keywords

  • breast cancer
  • DNA methylation
  • prognosis
  • endocrine treatment

Fingerprint

Dive into the research topics of 'Epigenetic profiling of hormone receptor positive breast cancer and the risk of disease recurrence'. Together they form a unique fingerprint.

Cite this